发明名称 |
Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications |
摘要 |
The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an HMG CoA reductase inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor.
|
申请公布号 |
US6462091(B1) |
申请公布日期 |
2002.10.08 |
申请号 |
US19990466414 |
申请日期 |
1999.12.17 |
申请人 |
G.D. SEARLE & CO. |
发明人 |
KELLER BRADLEY T.;SIKORSKI JAMES A.;GLENN KEVIN C.;CONNOLLY DANIEL T.;SMITH MARK E. |
分类号 |
A61K31/09;A61K31/133;A61K31/136;A61K31/22;A61K31/225;A61K31/366;A61K31/55;A61K31/575;A61K31/585;A61K31/785;A61K45/06;A61P9/00;A61P9/10;(IPC1-7):A61K31/136 |
主分类号 |
A61K31/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|